rs143886167

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_003193.5(TBCE):ā€‹c.253A>Gā€‹(p.Ile85Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000648 in 1,613,842 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00072 ( 0 hom., cov: 31)
Exomes š‘“: 0.00064 ( 4 hom. )

Consequence

TBCE
NM_003193.5 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: -0.327
Variant links:
Genes affected
TBCE (HGNC:11582): (tubulin folding cofactor E) Cofactor E is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004742801).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000716 (109/152198) while in subpopulation NFE AF= 0.00075 (51/68024). AF 95% confidence interval is 0.000586. There are 0 homozygotes in gnomad4. There are 66 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TBCENM_003193.5 linkuse as main transcriptc.253A>G p.Ile85Val missense_variant 4/17 ENST00000642610.2 NP_003184.1
TBCENM_001287801.2 linkuse as main transcriptc.253A>G p.Ile85Val missense_variant 4/18 NP_001274730.1
TBCENM_001079515.3 linkuse as main transcriptc.253A>G p.Ile85Val missense_variant 4/17 NP_001072983.1
TBCENM_001287802.2 linkuse as main transcriptc.-143A>G 5_prime_UTR_variant 3/16 NP_001274731.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TBCEENST00000642610.2 linkuse as main transcriptc.253A>G p.Ile85Val missense_variant 4/17 NM_003193.5 ENSP00000494796 P1Q15813-1

Frequencies

GnomAD3 genomes
AF:
0.000716
AC:
109
AN:
152198
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00442
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000750
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000872
AC:
219
AN:
251150
Hom.:
0
AF XY:
0.000942
AC XY:
128
AN XY:
135832
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000653
Gnomad FIN exome
AF:
0.00527
Gnomad NFE exome
AF:
0.000758
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.000640
AC:
936
AN:
1461644
Hom.:
4
Cov.:
31
AF XY:
0.000638
AC XY:
464
AN XY:
727090
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00526
Gnomad4 NFE exome
AF:
0.000547
Gnomad4 OTH exome
AF:
0.000679
GnomAD4 genome
AF:
0.000716
AC:
109
AN:
152198
Hom.:
0
Cov.:
31
AF XY:
0.000888
AC XY:
66
AN XY:
74360
show subpopulations
Gnomad4 AFR
AF:
0.000169
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00442
Gnomad4 NFE
AF:
0.000750
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.000659
Hom.:
0
Bravo
AF:
0.000280
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000931
AC:
113
EpiCase
AF:
0.000491
EpiControl
AF:
0.000237

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsNov 21, 2016- -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 20, 2015- -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 22, 2024- -
Hypoparathyroidism-retardation-dysmorphism syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
TBCE-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesAug 13, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
0.10
DANN
Benign
0.42
DEOGEN2
Benign
0.086
T;T;T;T;T;.;T;T;T;.;.;.;.
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.016
N
LIST_S2
Benign
0.60
.;.;.;.;.;.;.;.;.;T;T;T;T
M_CAP
Benign
0.0036
T
MetaRNN
Benign
0.0047
T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.26
N;N;N;N;N;.;N;N;N;.;N;.;.
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-0.48
.;.;.;.;.;.;.;.;N;.;N;N;.
REVEL
Benign
0.033
Sift
Benign
0.59
.;.;.;.;.;.;.;.;T;.;T;T;.
Sift4G
Benign
0.93
.;.;.;.;.;.;.;.;T;.;T;T;.
Polyphen
0.0
B;B;B;B;B;.;B;B;B;.;.;.;.
Vest4
0.15, 0.17, 0.16
MVP
0.21
MPC
0.18
ClinPred
0.0083
T
GERP RS
-11
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.013
gMVP
0.33

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs143886167; hg19: chr1-235577815; API